Evommune, Inc. Common Stock (EVMN)

Last Price16.01

Change-1.62 (-9.19%)

NYSE · Last Trade: Dec 16th, 1:45 PM EST

Detailed Quote

Previous Close	17.63
Open	17.83
Bid	15.90
Ask	16.01
Day's Range	15.84 - 18.42
52 Week Range	16.70 - 24.03
Volume	97,052
Market Cap	-
PE Ratio (TTM)	-
EPS (TTM)	-
Dividend & Yield	N/A (N/A)
1 Month Average Volume	103,259

Chart

News & Press Releases

Evommune Reports Third Quarter 2025 Financial Results and Provides Business Update

Evommune, Inc. (NYSE: EVMN) (the “Company”), a clinical-stage biotechnology company developing innovative therapies that target key drivers of chronic inflammatory diseases, today announced financial results for the third quarter ended September 30, 2025, and provided a business update.

By Evommune, Inc. · Via Business Wire · December 11, 2025